Zhao, Qiuchen
Pramanik, Jhuma
Lu, Yongjin
Homer, Natalie Z. M. https://orcid.org/0000-0002-9262-2098
Imianowski, Charlotte J. https://orcid.org/0000-0002-7116-7591
Zhang, Baojie
Iqbal, Muhammad
Shaji, Sanu Korumadathil
Morris, Andrew Conway https://orcid.org/0000-0002-3211-3216
Roychoudhuri, Rahul https://orcid.org/0000-0002-5392-1853
Okkenhaug, Klaus https://orcid.org/0000-0002-9432-4051
Qiu, Pengfei https://orcid.org/0000-0001-6784-410X
Mahata, Bidesh https://orcid.org/0000-0002-4506-0184
Funding for this research was provided by:
Cancer Research UK (RCCFEL\100095)
RCUK | Biotechnology and Biological Sciences Research Council (BB/V006126/1)
RCUK | MRC | Medical Research Foundation (MR/V028995/1)
Article History
Received: 14 February 2024
Accepted: 16 April 2025
First Online: 26 April 2025
Competing interests
: BM, JP and SKS declare following competing interests. An UK patent application submitted (Title: Cancer Treatments. Reference Number: P370182GB. Patent Application Number: 2502017.3) partly based on the findings in this manuscript where BM, JP and SKS are co-inventors. All other authors declare no competing interests.